Invitation for Submissions: AI in Biomedical Engineering
AI in Biomedical Engineering: Call for Papers ππ€
Submissions welcome for research on AI’s role in medical advancements. Explore innovative applications and insights.
June 4, 2025
Follow us
latest articles
Discover the newest research about AI innovations in π§ͺ Drug Discovery.
Enhancing search strategies for systematic reviews on drug Harms: An evaluation of the utility of ChatGPT in error detection and keyword generation.
ChatGPT enhances drug harm reviews: 49% keyword recreation, 0.17 Jaccard similarity. Effective error detection tool! ππ
May 30, 2025
National Taiwan University Hospital Launches AI for Pancreatic Cancer Imaging
National Taiwan University Hospital introduces AI for pancreatic cancer imaging, enhancing early detection and diagnostic accuracy. π₯π»
May 28, 2025
Generative AI’s Role in Advancing Drug Development
Generative AI is enhancing drug development efficiency. The DiffSMol model shows a 61.4% success rate in creating promising drug candidates. πβ¨
May 27, 2025
Persist AI Raises $12 Million in Series A Funding and Launches Cloud Lab
Persist AI secures $12 million in funding and launches Cloud Lab, enhancing drug formulation efficiency with AI and robotics. π€π
May 22, 2025
Artificial intelligence approaches for anti-addiction drug discovery.
AI revolutionizes anti-addiction drug discovery, enhancing efficacy and speed in targeting complex neurochemical systems. ππ
May 22, 2025
Amphetamine use and Parkinson’s disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. π§ π
May 21, 2025
Identification of hub biomarkers in coronary artery disease patients using machine learning and bioinformatic analyses.
Machine learning reveals 11 hub biomarkers for coronary artery disease, highlighting ITM2B’s potential role in inflammation. π«π¬
May 19, 2025
Datavant Acquires Aetion to Enhance Real-World Evidence Capabilities
Datavant acquires Aetion to enhance real-world evidence capabilities in healthcare. This merger aims to improve data sharing and analytics. ππ€
May 16, 2025
Construction of Sonosensitizer-Drug Co-Assembly Based on Deep Learning Method.
Deep learning enhances sonosensitizer-drug co-assembly, achieving 90% precision and 96% recall for cancer therapy. π‘π¬
May 16, 2025